Granulomatous hepatitis following intravesical bacillus Calmette-Guerin therapy
Although intravesical bacillus Calmette-Guerin (BCG) administration is an effective method in the treatment of superficial urinary bladder carcinoma, some complications may arise such as a granulomatous reaction either in the urinary tract or, in rare cases, outside the urinary tract. We report in t...
Gespeichert in:
| Veröffentlicht in: | International urology and nephrology 1999, Vol.31 (1), p.49-53 |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 53 |
|---|---|
| container_issue | 1 |
| container_start_page | 49 |
| container_title | International urology and nephrology |
| container_volume | 31 |
| creator | Ozbakkaloglu, B Tünger, O Sürücüoglu, S Lekili, M Kandiloglu, A R |
| description | Although intravesical bacillus Calmette-Guerin (BCG) administration is an effective method in the treatment of superficial urinary bladder carcinoma, some complications may arise such as a granulomatous reaction either in the urinary tract or, in rare cases, outside the urinary tract. We report in this paper a case of granulomatous hepatitis following intravesical BCG administration. |
| doi_str_mv | 10.1023/A:1007119706336 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_69892482</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>386445291</sourcerecordid><originalsourceid>FETCH-LOGICAL-c195t-9b15d8fa4fffe395507909782ba9f69fe9cf4b243e554e8e3b585c18818fc9673</originalsourceid><addsrcrecordid>eNpd0L1PwzAQBXALgWgpzGwoYmALnD9js6EKClKlLjBHTnqmrpykOA6o_z1BlIXplp-e3jtCLincUmD87uGeAhSUmgIU5-qITKkseM6kFsdkChxoThXjE3LW91sAMBrglEwoCNAc-JSsFtG2Q-gam7qhzza4s8kn32euC6H78u175tsU7Sf2vrYhq2ztQxjl3IYGU8J8MWD0bZY2GO1uf05OnA09XhzujLw9Pb7On_PlavEyf1jmNTUy5aaicq2dFc455EZKKAyYQrPKGqeMQ1M7UTHBUUqBGnkltayp1lS72qiCz8jNb-4udh8D9qlsfF9jCLbFcUipjDZMaDbC639w2w2xHbuVjCqqlZA_6OqAhqrBdbmLvrFxX_79iX8DNnNqWQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>216186452</pqid></control><display><type>article</type><title>Granulomatous hepatitis following intravesical bacillus Calmette-Guerin therapy</title><source>MEDLINE</source><source>SpringerLink Journals</source><creator>Ozbakkaloglu, B ; Tünger, O ; Sürücüoglu, S ; Lekili, M ; Kandiloglu, A R</creator><creatorcontrib>Ozbakkaloglu, B ; Tünger, O ; Sürücüoglu, S ; Lekili, M ; Kandiloglu, A R</creatorcontrib><description>Although intravesical bacillus Calmette-Guerin (BCG) administration is an effective method in the treatment of superficial urinary bladder carcinoma, some complications may arise such as a granulomatous reaction either in the urinary tract or, in rare cases, outside the urinary tract. We report in this paper a case of granulomatous hepatitis following intravesical BCG administration.</description><identifier>ISSN: 0301-1623</identifier><identifier>EISSN: 1573-2584</identifier><identifier>DOI: 10.1023/A:1007119706336</identifier><identifier>PMID: 10408303</identifier><identifier>CODEN: IURNAE</identifier><language>eng</language><publisher>Netherlands: Springer Nature B.V</publisher><subject>Adjuvants, Immunologic - administration & dosage ; Adjuvants, Immunologic - adverse effects ; Adjuvants, Immunologic - therapeutic use ; Administration, Intravesical ; BCG Vaccine - administration & dosage ; BCG Vaccine - adverse effects ; BCG Vaccine - therapeutic use ; Carcinoma, Transitional Cell - drug therapy ; Granuloma - etiology ; Granuloma - pathology ; Hepatitis - etiology ; Hepatitis - pathology ; Humans ; Liver - pathology ; Male ; Middle Aged ; Urinary Bladder Neoplasms - drug therapy</subject><ispartof>International urology and nephrology, 1999, Vol.31 (1), p.49-53</ispartof><rights>Copyright (c) 1999 Kluwer Academic Publishers</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c195t-9b15d8fa4fffe395507909782ba9f69fe9cf4b243e554e8e3b585c18818fc9673</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,4010,27900,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10408303$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ozbakkaloglu, B</creatorcontrib><creatorcontrib>Tünger, O</creatorcontrib><creatorcontrib>Sürücüoglu, S</creatorcontrib><creatorcontrib>Lekili, M</creatorcontrib><creatorcontrib>Kandiloglu, A R</creatorcontrib><title>Granulomatous hepatitis following intravesical bacillus Calmette-Guerin therapy</title><title>International urology and nephrology</title><addtitle>Int Urol Nephrol</addtitle><description>Although intravesical bacillus Calmette-Guerin (BCG) administration is an effective method in the treatment of superficial urinary bladder carcinoma, some complications may arise such as a granulomatous reaction either in the urinary tract or, in rare cases, outside the urinary tract. We report in this paper a case of granulomatous hepatitis following intravesical BCG administration.</description><subject>Adjuvants, Immunologic - administration & dosage</subject><subject>Adjuvants, Immunologic - adverse effects</subject><subject>Adjuvants, Immunologic - therapeutic use</subject><subject>Administration, Intravesical</subject><subject>BCG Vaccine - administration & dosage</subject><subject>BCG Vaccine - adverse effects</subject><subject>BCG Vaccine - therapeutic use</subject><subject>Carcinoma, Transitional Cell - drug therapy</subject><subject>Granuloma - etiology</subject><subject>Granuloma - pathology</subject><subject>Hepatitis - etiology</subject><subject>Hepatitis - pathology</subject><subject>Humans</subject><subject>Liver - pathology</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Urinary Bladder Neoplasms - drug therapy</subject><issn>0301-1623</issn><issn>1573-2584</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1999</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNpd0L1PwzAQBXALgWgpzGwoYmALnD9js6EKClKlLjBHTnqmrpykOA6o_z1BlIXplp-e3jtCLincUmD87uGeAhSUmgIU5-qITKkseM6kFsdkChxoThXjE3LW91sAMBrglEwoCNAc-JSsFtG2Q-gam7qhzza4s8kn32euC6H78u175tsU7Sf2vrYhq2ztQxjl3IYGU8J8MWD0bZY2GO1uf05OnA09XhzujLw9Pb7On_PlavEyf1jmNTUy5aaicq2dFc455EZKKAyYQrPKGqeMQ1M7UTHBUUqBGnkltayp1lS72qiCz8jNb-4udh8D9qlsfF9jCLbFcUipjDZMaDbC639w2w2xHbuVjCqqlZA_6OqAhqrBdbmLvrFxX_79iX8DNnNqWQ</recordid><startdate>1999</startdate><enddate>1999</enddate><creator>Ozbakkaloglu, B</creator><creator>Tünger, O</creator><creator>Sürücüoglu, S</creator><creator>Lekili, M</creator><creator>Kandiloglu, A R</creator><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>3V.</scope><scope>7QP</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PHGZM</scope><scope>PHGZT</scope><scope>PJZUB</scope><scope>PKEHL</scope><scope>PPXIY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope></search><sort><creationdate>1999</creationdate><title>Granulomatous hepatitis following intravesical bacillus Calmette-Guerin therapy</title><author>Ozbakkaloglu, B ; Tünger, O ; Sürücüoglu, S ; Lekili, M ; Kandiloglu, A R</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c195t-9b15d8fa4fffe395507909782ba9f69fe9cf4b243e554e8e3b585c18818fc9673</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1999</creationdate><topic>Adjuvants, Immunologic - administration & dosage</topic><topic>Adjuvants, Immunologic - adverse effects</topic><topic>Adjuvants, Immunologic - therapeutic use</topic><topic>Administration, Intravesical</topic><topic>BCG Vaccine - administration & dosage</topic><topic>BCG Vaccine - adverse effects</topic><topic>BCG Vaccine - therapeutic use</topic><topic>Carcinoma, Transitional Cell - drug therapy</topic><topic>Granuloma - etiology</topic><topic>Granuloma - pathology</topic><topic>Hepatitis - etiology</topic><topic>Hepatitis - pathology</topic><topic>Humans</topic><topic>Liver - pathology</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Urinary Bladder Neoplasms - drug therapy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ozbakkaloglu, B</creatorcontrib><creatorcontrib>Tünger, O</creatorcontrib><creatorcontrib>Sürücüoglu, S</creatorcontrib><creatorcontrib>Lekili, M</creatorcontrib><creatorcontrib>Kandiloglu, A R</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>ProQuest Central (Corporate)</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest Central (New)</collection><collection>ProQuest One Academic (New)</collection><collection>ProQuest Health & Medical Research Collection</collection><collection>ProQuest One Academic Middle East (New)</collection><collection>ProQuest One Health & Nursing</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>International urology and nephrology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ozbakkaloglu, B</au><au>Tünger, O</au><au>Sürücüoglu, S</au><au>Lekili, M</au><au>Kandiloglu, A R</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Granulomatous hepatitis following intravesical bacillus Calmette-Guerin therapy</atitle><jtitle>International urology and nephrology</jtitle><addtitle>Int Urol Nephrol</addtitle><date>1999</date><risdate>1999</risdate><volume>31</volume><issue>1</issue><spage>49</spage><epage>53</epage><pages>49-53</pages><issn>0301-1623</issn><eissn>1573-2584</eissn><coden>IURNAE</coden><abstract>Although intravesical bacillus Calmette-Guerin (BCG) administration is an effective method in the treatment of superficial urinary bladder carcinoma, some complications may arise such as a granulomatous reaction either in the urinary tract or, in rare cases, outside the urinary tract. We report in this paper a case of granulomatous hepatitis following intravesical BCG administration.</abstract><cop>Netherlands</cop><pub>Springer Nature B.V</pub><pmid>10408303</pmid><doi>10.1023/A:1007119706336</doi><tpages>5</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0301-1623 |
| ispartof | International urology and nephrology, 1999, Vol.31 (1), p.49-53 |
| issn | 0301-1623 1573-2584 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_69892482 |
| source | MEDLINE; SpringerLink Journals |
| subjects | Adjuvants, Immunologic - administration & dosage Adjuvants, Immunologic - adverse effects Adjuvants, Immunologic - therapeutic use Administration, Intravesical BCG Vaccine - administration & dosage BCG Vaccine - adverse effects BCG Vaccine - therapeutic use Carcinoma, Transitional Cell - drug therapy Granuloma - etiology Granuloma - pathology Hepatitis - etiology Hepatitis - pathology Humans Liver - pathology Male Middle Aged Urinary Bladder Neoplasms - drug therapy |
| title | Granulomatous hepatitis following intravesical bacillus Calmette-Guerin therapy |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-15T01%3A37%3A05IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Granulomatous%20hepatitis%20following%20intravesical%20bacillus%20Calmette-Guerin%20therapy&rft.jtitle=International%20urology%20and%20nephrology&rft.au=Ozbakkaloglu,%20B&rft.date=1999&rft.volume=31&rft.issue=1&rft.spage=49&rft.epage=53&rft.pages=49-53&rft.issn=0301-1623&rft.eissn=1573-2584&rft.coden=IURNAE&rft_id=info:doi/10.1023/A:1007119706336&rft_dat=%3Cproquest_pubme%3E386445291%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=216186452&rft_id=info:pmid/10408303&rfr_iscdi=true |